I'm very concerned about this decline in confidence we see in the public when it comes to the COVID vaccine.
I wanted to just take a moment to address an argument that we heard articulated today by these companies, which is that ...
Trust of the vaccine will be as important, if not more so, than the safety and efficacy.
But nevertheless, I don't think it is fair to try to push the blame off particularly onto the PBMs. It is the pharmaceut...
That's not a good situation to be in. That's very alarming as we're trying to tackle this pandemic.
if you're fighting with the public health experts, you're politicizing this, and if you're allying yourself with them, t...
They are furious about it because they say they deplore his politics, and they don't want to be associated with it.
In just a little example, Copaxone cost our constituents $126 a day, which is four times what it costs in Germany.
I am particularly thankful that you are holding this hearing.
But to use the word 'collapse' after you have raised the drug price 27 times... is a little bit misleading.
Your company has made more than $34 billion--$34 billion--from Copaxone but it reported to the committee that it has spe...
Thank you very much, Madam Chair, for calling this extremely important hearing.
Your companies raised the price of Copaxone 27 different times since bringing it to market more than two decades ago.
The President has failed to fulfill his promise. We are here to keep Elijah's commitment.
But we are told if we put any limits on price increases in America, we will stifle innovation.
this is precisely why we need to give the government and Medicare the power to negotiate for lower drug prices because o...
How can you justify increasing the prices of this desperately needed drug while there have been no investments in scient...
We need to make sure that consumers and everyday voices are a recognized constituency group and help build our policy ar...
